Osiris Therapeutics (OSIR) Misses Q2 EPS by 20c
Tweet
Share
E-mailGet Alerts OSIR Hot Sheet
Price: $18.99 --0%
Financial Fact:
Basic earnings per share (in dollars per share): -0.02
Today's EPS Names:
DIT, AMC, DPZ, More
Financial Fact:
Basic earnings per share (in dollars per share): -0.02
Today's EPS Names:
DIT, AMC, DPZ, More
Join SI Premium – FREE
Osiris Therapeutics (NASDAQ: OSIR) reported Q2 EPS of ($0.04), $0.20 worse than the analyst estimate of $0.16. Revenue for the quarter came in at $13.3 million versus the consensus estimate of $11 million.
For earnings history and earnings-related data on Osiris Therapeutics (OSIR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA expects Apple to top analyst expectations on July 30
- EVI Industries to acquire Sudsies in consumer garment care expansion
- DA Davidson Reiterates Buy Rating on Tractor Supply Company (TSCO) Amid Soft Q2 Expectations
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
